Literature DB >> 10775832

Improved selective, simple, and contrast staining of acidophilic neurons with vanadium acid fuchsin.

I V Victorov1, K Prass, U Dirnagl.   

Abstract

Acidophilia is one of the hallmarks of acute neuronal damage and death in brain ischemia, excitotoxic and traumatic lesions and epileptic seizures. We here describe a novel and simple method for visualizing acidophilic neurons on paraffin sections, using vanadium acid fuchsin (VAF) staining and toluidine blue or hematoxylin counterstaining. Paraffin sections of the brain fixed in ethanol-formalin-acetic acid mixture are stained in 0.1% acid fuchsin containing 0.125% of ammonium metavanadate and 1% of glacial acetic acid, differentiated if overstained in 0.01% of borax solution, and counterstained with 0.05-0.025% of toluidine blue in acetate buffer (pH 3.3) or Gill's II hematoxylin. The sections are dehydrated, cleared in xylene and mounted in Canada balsam or any synthetic mounting media for light microscopy. VAF combined with toluidine blue or hematoxylin results in highly selective and reproducible color contrast staining of acidophilic neurons as well as glial nuclei and hyperchromatic neurons. As a progressive method, acid fuchsin staining usually does not require differentiation. The red acidophilic neurons are clearly visible on the background of non-damaged cells, which significantly facilitates the identification, and localization of damaged neurons, even at low magnification under the light microscope.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10775832     DOI: 10.1016/s1385-299x(00)00004-0

Source DB:  PubMed          Journal:  Brain Res Brain Res Protoc        ISSN: 1385-299X


  8 in total

Review 1.  Ultrasound for drug and gene delivery to the brain.

Authors:  Kullervo Hynynen
Journal:  Adv Drug Deliv Rev       Date:  2008-04-06       Impact factor: 15.470

2.  Rapid Intramitochondrial Zn2+ Accumulation in CA1 Hippocampal Pyramidal Neurons After Transient Global Ischemia: A Possible Contributor to Mitochondrial Disruption and Cell Death.

Authors:  Hong Z Yin; Hwai-Lee Wang; Sung G Ji; Yuliya V Medvedeva; Guilian Tian; Afsheen K Bazrafkan; Niki Z Maki; Yama Akbari; John H Weiss
Journal:  J Neuropathol Exp Neurol       Date:  2019-07-01       Impact factor: 3.685

3.  Focused ultrasound modulates region-specific brain activity.

Authors:  Seung-Schik Yoo; Alexander Bystritsky; Jong-Hwan Lee; Yongzhi Zhang; Krisztina Fischer; Byoung-Kyong Min; Nathan J McDannold; Alvaro Pascual-Leone; Ferenc A Jolesz
Journal:  Neuroimage       Date:  2011-02-24       Impact factor: 6.556

4.  Noninvasive localized delivery of Herceptin to the mouse brain by MRI-guided focused ultrasound-induced blood-brain barrier disruption.

Authors:  Manabu Kinoshita; Nathan McDannold; Ferenc A Jolesz; Kullervo Hynynen
Journal:  Proc Natl Acad Sci U S A       Date:  2006-07-25       Impact factor: 11.205

5.  Blocking mitochondrial Zn2+ accumulation after ischemia reduces mitochondrial dysfunction and neuronal injury.

Authors:  Yuliya V Medvedeva; Hong Z Yin; Afsheen Bazrafkan; Andriy Yeromin; Sung G Ji; Eli J Weiss-Hung; Edward Sharman; Alyssa P Avilez; Niki Maki; Masih A Rafi; Guilian Tian; Yama Akbari; John H Weiss
Journal:  J Neurosci       Date:  2022-05-27       Impact factor: 6.709

6.  Morphofunctional changes in the rat spinal cord after focal photothrombosis.

Authors:  S S Pashin; I V Viktorov
Journal:  Neurosci Behav Physiol       Date:  2009-01-13

7.  Nanotechnology for CNS delivery of bio-therapeutic agents.

Authors:  Lipa Shah; Sunita Yadav; Mansoor Amiji
Journal:  Drug Deliv Transl Res       Date:  2013-08-01       Impact factor: 4.617

8.  Single-cell resolution mapping of neuronal damage in acute focal cerebral ischemia using thallium autometallography.

Authors:  Franziska Stöber; Kathrin Baldauf; Iryna Ziabreva; Denise Harhausen; Marietta Zille; Jenni Neubert; Klaus G Reymann; Henning Scheich; Ulrich Dirnagl; Ulrich H Schröder; Andreas Wunder; Jürgen Goldschmidt
Journal:  J Cereb Blood Flow Metab       Date:  2013-10-16       Impact factor: 6.200

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.